Precision Biosensor Past Earnings Performance
Past criteria checks 0/6
Precision Biosensor's earnings have been declining at an average annual rate of -13.1%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 24% per year.
Key information
-13.1%
Earnings growth rate
-5.7%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 24.0% |
| Return on equity | -14.0% |
| Net Margin | -22.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Precision Biosensor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 20,391 | -4,490 | 7,529 | 3,196 |
| 30 Sep 23 | 20,570 | -4,231 | 7,611 | 2,995 |
| 30 Jun 23 | 20,885 | -5,056 | 7,512 | 3,037 |
| 31 Mar 23 | 19,787 | -7,016 | 7,461 | 2,840 |
| 31 Dec 22 | 20,458 | -6,806 | 7,601 | 2,611 |
| 30 Sep 22 | 22,808 | -6,251 | 7,495 | 2,463 |
| 30 Jun 22 | 23,500 | -4,733 | 7,814 | 1,752 |
| 31 Mar 22 | 21,233 | -3,308 | 7,742 | 1,509 |
| 31 Dec 21 | 15,887 | -4,152 | 6,305 | 1,958 |
| 30 Sep 21 | 14,255 | -2,250 | 5,414 | 2,084 |
| 30 Jun 21 | 11,111 | -2,215 | 4,967 | 2,084 |
| 31 Mar 21 | 9,447 | -4,947 | 4,158 | 2,240 |
| 31 Dec 20 | 8,685 | -4,953 | 3,907 | 2,045 |
Quality Earnings: A335810 is currently unprofitable.
Growing Profit Margin: A335810 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A335810's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare A335810's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A335810 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).
Return on Equity
High ROE: A335810 has a negative Return on Equity (-14.02%), as it is currently unprofitable.